To Evaluate the Role of Virechana Karma along with Kanchanara Varuna Ghan Vati in Garbhashaya Arbuda with special reference to Uterine Fibroid.

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

CTRI

Registry ID

CTRI/2019/05/019455

Enrollment

Registered

2019-05-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: - Health Condition 3: C55- Malignant neoplasm of uterus, partunspecified

Interventions

Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: A)Having fibroid size upto 5cms (confirmed by U.S.G.) B)Single or multiple uterine fibroid. C)Female patients of Age 20-50 years

Exclusion criteria

Exclusion criteria: 1.Patients having bleeding due to abortion. 2.Patients having coagulation disorders. 3.Fibroid size > 5cm. 4.Any type of malignancy. 5.Pregnant woman. 6.Patients having any systemic disease. 7.Patients using IUCDs. 8.Patient having haemoglobin percentage less than 7gm/dl

Design outcomes

Primary

Measure	Time frame
Clinical Evaluation Of Efficacy Of Virechana Karma along with Kanchanara Varuna Ghan Vati in Garbhashaya Arbuda (Uterine Fibroid)Timepoint: 90 days	—

Secondary

Measure	Time frame
To Evaluate Clinical Efficacy Of Virechana Karma Procedure By Using Trivrit Lehya along with Kanchanara Varuna Ghan Vati in Garbhashaya Arbuda (Uterine Fibroid)Timepoint: 90 days	—

Countries

India

Contacts

Public ContactTagu

National Institue Of Ayurveda

baruhunt@gmail.com9982678508

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026